Doncheva et al., 2009 - Google Patents
P452 CLINICAL OBSERVATION STUDY ON OMEGA-3 FATTY ACIDS EFFECTS ON ATHEROSCLEROSIS RISK FACTORS IN DYSLIPIDAEMIC AND MODERATE …Doncheva et al., 2009
- Document ID
- 568624110444172318
- Author
- Doncheva N
- Niagolov Y
- Publication year
- Publication venue
- Atherosclerosis Supplements
External Links
- 235000020660 omega-3 fatty acid 0 title abstract description 9
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vijaimohan et al. | Beneficial effects of alpha linolenic acid rich flaxseed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rats | |
| Grimm et al. | Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients | |
| JP6387371B2 (en) | Metabolic syndrome improver | |
| Pottel et al. | Omega-3 fatty acids: physiology, biological sources and potential applications in supportive cancer care | |
| WO2011097273A1 (en) | Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl lcystenine | |
| JP7762572B2 (en) | Very long chain fatty acids for the treatment and alleviation of disease | |
| JP2018021067A (en) | How to reduce the risk of pathological effects of traumatic brain injury | |
| Rockett et al. | High dose of an n-3 polyunsaturated fatty acid diet lowers activity of C57BL/6 mice | |
| CN116019149B (en) | Formula food fat component with special medical application | |
| JP2006016408A (en) | Blood neutral fat inhibitor | |
| Doncheva et al. | P452 CLINICAL OBSERVATION STUDY ON OMEGA-3 FATTY ACIDS EFFECTS ON ATHEROSCLEROSIS RISK FACTORS IN DYSLIPIDAEMIC AND MODERATE HYPERTENSION PATIENTS | |
| WO2015050071A1 (en) | Nutritional supplement and agent for improving cardiovascular diseases | |
| Borghi et al. | Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management | |
| Behera | Dietary fish oil concentrates associated health benefits: A recent development of cardiovascular risk reduction | |
| Chukwuma et al. | Effects of dietary fish oil replacement with rice bran oil on growth performance, serum biochemical index, antioxidant capacity, lipid metabolism and inflammatory response of large yellow croaker (Larimichthys crocea) juveniles | |
| CN103766507A (en) | Edible oil with health-care function | |
| CN105286020B (en) | A kind of nutritional composition for non-dialysis patients | |
| EP3062788A1 (en) | Monoacylglycerols and fat-soluble nutrients for use in the treatment of malabsorption having a non-mechanical basis | |
| Bellows et al. | Omega-3 Fatty Acids | |
| CN102232431A (en) | Health-care oil | |
| FR2970152B1 (en) | FOOD COMPOSITION BASED ON ALGAE EXTRACT FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY | |
| Currie et al. | Assessment of the Relative Absorbability of Orally Dosed Whole Marine Oils and A Standard, Processed 18/12 Omega-3 Oil-Does Nature Know Best? | |
| Calder et al. | Fish oils | |
| Hegde et al. | 705 OMEGA-3 FATTY ACID ENRICHED EGGS ARE HEART FRIENDLY | |
| Van Rensburg | Adolescents-brain food: fish oils-omega-3 fatty acids: family feature |